DE60323214D1 - Verfahren und zusammensetzungen für die pharmakologische und toxikologische auswertung von testsubstanzen - Google Patents

Verfahren und zusammensetzungen für die pharmakologische und toxikologische auswertung von testsubstanzen

Info

Publication number
DE60323214D1
DE60323214D1 DE60323214T DE60323214T DE60323214D1 DE 60323214 D1 DE60323214 D1 DE 60323214D1 DE 60323214 T DE60323214 T DE 60323214T DE 60323214 T DE60323214 T DE 60323214T DE 60323214 D1 DE60323214 D1 DE 60323214D1
Authority
DE
Germany
Prior art keywords
pharmacological
compositions
test substances
toxicological evaluation
animals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60323214T
Other languages
English (en)
Inventor
Howard J Jacobs
Richard J Roman
Steven H Nye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHYSIOGENIX Inc
Original Assignee
PHYSIOGENIX Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PHYSIOGENIX Inc filed Critical PHYSIOGENIX Inc
Application granted granted Critical
Publication of DE60323214D1 publication Critical patent/DE60323214D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/142Toxicological screening, e.g. expression profiles which identify toxicity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
DE60323214T 2002-03-05 2003-03-04 Verfahren und zusammensetzungen für die pharmakologische und toxikologische auswertung von testsubstanzen Expired - Fee Related DE60323214D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36189002P 2002-03-05 2002-03-05
PCT/US2003/006421 WO2003075838A2 (en) 2002-03-05 2003-03-04 Methods and compositions for pharmacological and toxicological evaluation of test agents

Publications (1)

Publication Number Publication Date
DE60323214D1 true DE60323214D1 (de) 2008-10-09

Family

ID=27805091

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60323214T Expired - Fee Related DE60323214D1 (de) 2002-03-05 2003-03-04 Verfahren und zusammensetzungen für die pharmakologische und toxikologische auswertung von testsubstanzen

Country Status (8)

Country Link
US (1) US20030237103A1 (de)
EP (1) EP1487261B1 (de)
JP (1) JP2005520503A (de)
AT (1) ATE406093T1 (de)
AU (1) AU2003216489A1 (de)
DE (1) DE60323214D1 (de)
DK (1) DK1487261T3 (de)
WO (1) WO2003075838A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE513838T1 (de) 2002-09-20 2011-07-15 Promega Corp Auf lumineszenz basierende verfahren und sonden zur messung der cytochrom-p450-aktivität
WO2006130551A2 (en) * 2005-05-31 2006-12-07 Promega Corporation Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
US8612176B2 (en) * 2007-01-26 2013-12-17 Auburn University Nominal population metric: clustering of nominal application attributes
US7844609B2 (en) * 2007-03-16 2010-11-30 Expanse Networks, Inc. Attribute combination discovery
WO2010021686A1 (en) * 2008-08-18 2010-02-25 Promega Corporation Luminogenic compounds and methods to detect cytochrome p450 3a enzymes
WO2010077336A1 (en) 2008-12-31 2010-07-08 23Andme, Inc. Finding relatives in a database
EP3099683B1 (de) 2014-01-29 2020-08-05 Promega Corporation Chinonmaskierte sonden als markierungsreagenzien für zellaufnahmemessungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992007095A1 (en) * 1990-10-15 1992-04-30 Stratagene Arbitrarily primed polymerase chain reaction method for fingerprinting genomes
US5580728A (en) * 1994-06-17 1996-12-03 Perlin; Mark W. Method and system for genotyping
WO1999040226A2 (en) * 1998-02-04 1999-08-12 Perkin-Elmer Corporation Determination of a genotype of an amplification product at multiple allelic sites
US6534574B1 (en) * 2001-03-24 2003-03-18 Milliken & Company Highly nucleated thermoplastic articles
US6465551B1 (en) * 2001-03-24 2002-10-15 Milliken & Company Bicyclo[2.2.1]heptane dicarboxylate salts as polyolefin nucleators

Also Published As

Publication number Publication date
AU2003216489A1 (en) 2003-09-22
DK1487261T3 (da) 2008-11-24
WO2003075838A3 (en) 2003-12-04
US20030237103A1 (en) 2003-12-25
EP1487261B1 (de) 2008-08-27
ATE406093T1 (de) 2008-09-15
EP1487261A4 (de) 2005-04-13
WO2003075838A2 (en) 2003-09-18
EP1487261A2 (de) 2004-12-22
JP2005520503A (ja) 2005-07-14
AU2003216489A8 (en) 2003-09-22

Similar Documents

Publication Publication Date Title
ATE513911T1 (de) Verfahren und zusammensetzungen für rna- interferenz
ATE516497T1 (de) Screening für funktionshomologien
DE60118660D1 (de) Zusammensetzungen und Verfahren zum Nachweis von Mais-Transformante PV-ZMGT32 (NK603)
DE60207514D1 (de) Zusammensetzungen und Verfahren zum Nachweis und zur Behandlung von mit Chemokinrezeptoren verbundenen Krankheiten
DE602005016892D1 (de) Nukleinsäurecharakterisierung
IL177495A0 (en) Methods of isolating and identifying cells using signaling probes
DE602004027761D1 (de) Verfahren zum Auswählen und Aufnehmen von Tierzellenkolonien
ATA8612001A (de) Verfahren zum testen von software
DE60318642D1 (de) Multi-Test-Analyse von Echzeit-Nukleinsäureamplifikationen
DE602004030372D1 (de) Verfahren zur Bestimmung des relativen genetischen Risikos für Autismus
DE60323214D1 (de) Verfahren und zusammensetzungen für die pharmakologische und toxikologische auswertung von testsubstanzen
DE60335812D1 (de) Biosensor und verfahren zu seiner herstellung
CY1110138T1 (el) Προσδιορισμος υψηλης διεκπεραιωτικοτητας της δραστικοτητας lp-pla2
DE60133366D1 (de) Irak-4 zusammensetzungen und deren verwendungen
DE60305821D1 (de) Verfahren zum Wiegen von Poststücken
WO2001087055A3 (en) New screening tool for analyzing the behavior of laboratory animals
DE60327307D1 (de) Verfahren zur abschätzung von bodenreaktion von zweibeinigen beweglichen körpern
ATE474049T1 (de) Nukleinsäuren aus monocyten und verwandte zusammensetzungen und verfahren
DE60322829D1 (de) Verfahren zum Prüfen
ATE420162T1 (de) Verfahren und zusammensetzungen zum targeting sekretorischer lysosomen
ID23328A (id) Proses pembuatan bubur kayu kimiawi
ATE242781T1 (de) Verfahren, kit und dna-sonden zum nachweis einer pilz-spezies in klinischem material
TR200200208T2 (tr) C.Albicans esas genleri ve antimikotik maddelerin taranması yöntemi
MD1261F1 (en) Method for evaluation of the triticale genotypes resistance to fusariose
EP1483962A3 (de) Transgenes Tiermodel für Glyt1 Funktion

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee